-
Tazemetostat hydrobromide
- names:
Tazemetostat hydrobromide
- CAS号:
1467052-75-0
MDL Number: - MF(分子式): C34H45BrN4O4 MW(分子量): 653.65
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM003070-10mg | 10mg | 99.18% | ¥ 2835.00 | ¥ 2835.00 | 2-3天 | ¥ 0.00 | ||
| YZM003070-5mg | 5mg | 99.18% | ¥ 780.00 | ¥ 780.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | |
| CAS号 | 1467052-75-0 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C34H45BrN4O4 |
| 分子量 Molecular Weight | 653.65 |
| 溶解度Solubility | 生物体外In Vitro:DMSO溶解度100 mg/mL(152.99 mM;Need ultrasonic) |
| 性状 | |
| 储藏条件 Storage conditions | 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
Tazemetostat hydrobromide(CAS:1467052-75-0)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
| 产品说明 | Tazemetostat hydrobromide (EPZ-6438 hydrobromide) 是一种有效的,选择性,口服的EZH2抑制剂 |
| Introduction | Tazemetostat hydrobromide (EPZ438 hydrobromide) is a potent, selective and orally availableEZH2inhibitor. Tazemetostat hydrobromide inhibits the activity of human polycomb repressive complex 2 (PRC2)ontaining wildype EZH2 with aKivalue of 2.5 nM. Tazemetostat hydrobromide inhibits EZH2 with IC50s of 11 and 16 nM in peptide assay and nucleosome assay, respectively. Tazemetostat hydrobromide inhibits Rat EZH2 with an IC50of 4 nM. Tazemetostat hydrobromide also inhibits EZH1 with an IC50of 392 nM. |
| Application1 | |
| Application2 | |
| Application3 |
Tazemetostat hydrobromide (EPZ-6438 hydrobromide) 是一种有效的,选择性,口服的EZH2抑制剂。Tazemetostat hydrobromide 抑制含有 PRC2 复合体的野生型 EZH2 的活性,Ki值为 2.5±0.5 nM。Tazemetostat hydrobromide 抑制 EZH2,在肽测定和核小体测定中 IC50分别为 11 和 16 nM。Tazemetostat hydrobromide 抑制大鼠 EZH2,IC50为 4 nM。Tazemetostat hydrobromide 还抑制 EZH1,IC50为 392 nM。Tazemetostat hydrobromide (EPZ-6438 hydrobromide) is a potent, selective and orally availableEZH2inhibitor. Tazemetostat hydrobromide inhibits the activity of human polycomb repressive complex 2 (PRC2)-containing wild-type EZH2 with aKivalue of 2.5 nM. Tazemetostat hydrobromide inhibits EZH2 with IC50s of 11 and 16 nM in peptide assay and nucleosome assay, respectively. Tazemetostat hydrobromide inhibits Rat EZH2 with an IC50of 4 nM. Tazemetostat hydrobromide also inhibits EZH1 with an IC50of 392 nM.
【1】.Knutson SK, et al. Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferaseEZH2. Proc Natl Acad Sci U S A. 2013 May 7;110(19):7922-7.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


